Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reporting completion of a study evaluating Albuferon in combination with ribavirin for treatment-naive chronic hepatitis C patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Albuferon (albuferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED